« « Eat This, Not That! It's the Best of Food, It's the Worst of Food 
|  USF receives $128 million award for diabetes research – Bizjournals.com » »
AtheroGenics diabetes drug trial meets main goal – Reuters
Friday, August 1st, 2008    Subscribe To Our Feed|
AtheroGenics diabetes drug trial meets main goal
Reuters - 13 hours ago O: Quote, Profile, Research) said both doses of its experimental drug, AGI-1067, met the main goal in a late-stage trial to treat type 2 diabetes to reduce … AtheroGenics Reports Positive Results From ANDES Phase 3 Clinical … MarketWatch all 13 news articles |
Source:AtheroGenics diabetes drug trial meets main goal – Reuters
Posted in insulin | Trackback | del.icio.us | Top Of Page
Site Search Tags: No Tags
Technorati Tags: No Tags
Related Tags: No Tags
Technorati Tags: No Tags
Related Tags: No Tags
Possible Related Posts
UPDATE 1-Elixir Pharma's oral diabetes drug meets trial goal – ReutersUPDATE 1-Roche, Ipsen launch pivotal trial of diabetes drug – ReutersNovo Nordisk diabetes drug tops Byetta in trial – guardian.co.uk